# Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution

> **NCT04935320** · PHASE1 · COMPLETED · sponsor: **Nxera Pharma UK Limited** · enrollment: 15 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HTL0016878.HCl Solution 10 mg
- **DRUG:** HTL0016878.Citrate Capsule 10 mg

## Key facts

- **NCT ID:** NCT04935320
- **Lead sponsor:** Nxera Pharma UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2021-10-29
- **Final completion:** 2021-10-29
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935320, "Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04935320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*